Related references
Note: Only part of the references are listed.seeQTL: a searchable database for human eQTLs
Kai Xia et al.
BIOINFORMATICS (2012)
Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonβ therapy in multiple sclerosis
S. Vosslamber et al.
GENES AND IMMUNITY (2011)
The Ubiquitin-Editing Protein A20 Prevents Dendritic Cell Activation, Recognition of Apoptotic Cells, and Systemic Autoimmunity
Mirjam Kool et al.
IMMUNITY (2011)
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
Ludwig Kappos et al.
LANCET (2011)
Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course
Mohsen Khademi et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Stephen Sawcer et al.
NATURE (2011)
SCAN: SNP and copy number annotation
Eric R. Gamazon et al.
BIOINFORMATICS (2010)
Polymorphisms in the IL2, IL2RA and IL2RB genes in multiple sclerosis risk
Maria L. Cavanillas et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2010)
Multiple loci comprising immune-related genes regulate experimental neuroinflammation
M. Marta et al.
GENES AND IMMUNITY (2010)
RGMA and IL21R show association with experimental inflammation and multiple sclerosis
R. Nohra et al.
GENES AND IMMUNITY (2010)
IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci
F. Esposito et al.
GENES AND IMMUNITY (2010)
The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosis
A. Alcina et al.
GENES AND IMMUNITY (2010)
The Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS)
Johannes Brettschneider et al.
PLOS ONE (2010)
A Role for VAV1 in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
Maja Jagodic et al.
SCIENCE TRANSLATIONAL MEDICINE (2009)
Increased CXCL-13 levels in human African trypanosomiasis meningo-encephalitis
Bertrand Courtioux et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2009)
Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus
Stacy L. Musone et al.
NATURE GENETICS (2008)
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
Jeffrey C. Barrett et al.
NATURE GENETICS (2008)
B-cell depletion with Rituximab in relapsing-remitting multiple sclerosis
Stephen L. Hauser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Cerebrospinal Fluid B Cells Correlate with Early Brain Inflammation in Multiple Sclerosis
Bettina Kuenz et al.
PLOS ONE (2008)
Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations
G. Kristjansdottir et al.
JOURNAL OF MEDICAL GENETICS (2008)
PLINK: A tool set for whole-genome association and population-based linkage analyses
Shaun Purcell et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment
M Krumbholz et al.
BRAIN (2006)
The chemokine CXCL13 (BLC): A putative diagnostic marker for neuroborreliosis
TA Rupprecht et al.
NEUROLOGY (2005)
Two discrete promoters regulate the alternatively spliced human interferon regulatory factor-5 isoforms
ME Mancl et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The basic helix-loop-helix olig3 establishes the neural plate boundary of the trunk and is necessary for development of the dorsal spinal cord
A Filippi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors
A Takaoka et al.
NATURE (2005)
Resolution of a 16.8-mb autoimmunity-regulating rat chromosome 4 region into multiple encephalomyrelitis quantitative trait loci and evidence for epistasis
M Jagodic et al.
JOURNAL OF IMMUNOLOGY (2005)
De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling
IE Wertz et al.
NATURE (2004)
Abnormal B-cell responses to chemokines, disturbed plasma cell localization, and distorted immune tissue architecture in Rgs1-/- mice
C Moratz et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course
LF Barcellos et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
HLA DRB1*1501 and intrathecal inflammation in multiple sclerosis
F Sellebjerg et al.
TISSUE ANTIGENS (2000)
Regulator of G protein signaling 1 (RGS1) markedly impairs Giα signaling responses of B lymphocytes
C Moratz et al.
JOURNAL OF IMMUNOLOGY (2000)